A 58-year-old male patient presents with a five-year history of suprapubic pain, nocturia, dysuria, recurrent urinary tract ...

LOS ANGELES, CA– In a groundbreaking achievement set to reshape the future of transplant medicine, Dr. Inderbir S. Gill has led the world’s first successful bladder transplant in a human being ...

Mass spectrometry is an analytical technique that uses an instrument called a mass spectrometer to measure the mass-to-charge ratios of molecular ions. Molecules fragment within the mass ...

Bladder cancer is a biologically heterogeneous disease, and ongoing efforts in biomarker research aim to support personalized treatment approaches. Circulating tumour DNA is approaching clinical ...

J&J's TAR-200 drug fails a phase 3 bladder cancer trial, but the company is still confident in the blockbuster potential of the programme.

Johnson & Johnson has started a marketing application in the US for TAR-200 as a treatment for non-muscle-invasive bladder cancer (NMIBC).